N-acetyl cysteine (NAC) sits in an unusual position among PCOS supplements: it has genuine clinical trial data—including head-to-head trials with metformin—but it remains far less discussed than inositol or berberine. For women with PCOS who have not found adequate relief from first-line interventions, or who want to address the oxidative stress component of PCOS that other supplements do not target directly, NAC deserves a careful look.
Why PCOS has an oxidative stress component
PCOS is not simply a hormonal disorder—it has a significant metabolic and oxidative stress component that is often underappreciated. Hyperinsulinemia (elevated insulin levels, common in PCOS) generates reactive oxygen species (ROS) through several mechanisms: increased glucose oxidation in mitochondria, activation of NADPH oxidase, and disruption of the normal antioxidant enzyme balance.
This oxidative stress feeds back into the hormonal picture. ROS in ovarian tissue impairs follicle development, disrupts normal steroidogenesis (hormone production), and may directly contribute to elevated androgen levels. Women with PCOS consistently show higher markers of oxidative stress—lower glutathione, higher malondialdehyde, elevated inflammatory markers—compared to non-PCOS women even when controlling for BMI.
The implications are important: antioxidant interventions that specifically target the glutathione pathway may address PCOS through mechanisms that standard insulin sensitizers do not cover. This is where NAC enters.
How NAC works in PCOS
NAC's primary mechanism is as a precursor to glutathione, the body's master antioxidant. Glutathione is synthesized intracellularly from three amino acids: glycine, glutamate, and cysteine. Cysteine is the rate-limiting precursor—meaning the availability of cysteine largely determines how much glutathione your cells can make. NAC is essentially a stable, bioavailable form of cysteine that crosses cell membranes readily and replenishes intracellular glutathione stores.
In the context of PCOS, elevated glutathione does several things: it directly neutralizes the ROS generated by hyperinsulinemia, it reduces lipid peroxidation in ovarian tissue, and it improves mitochondrial function in granulosa cells (which support follicle development).
NAC also has a second relevant mechanism that is somewhat independent of glutathione: it appears to improve insulin sensitivity through pathways adjacent to but distinct from classic AMPK activation. Some research suggests NAC reduces the inflammatory signaling (NFkB pathway) that contributes to insulin receptor dysfunction in PCOS.
Clinical trials: the evidence
The most cited NAC-PCOS study is Nasr (2010), which randomized PCOS women with insulin resistance to either NAC (1.8g/day) or metformin (1500mg/day) for 24 weeks. The NAC group showed statistically significant improvements in insulin resistance (measured by HOMA-IR), total testosterone, and menstrual frequency comparable to the metformin group—with significantly fewer GI side effects. This is a striking finding: a supplement performing comparably to a first-line pharmaceutical with better tolerability.
A 2015 study by Nasr compared NAC to clomiphene (a standard ovulation induction drug) and found that NAC combined with clomiphene produced higher ovulation rates, higher pregnancy rates, and higher live birth rates than clomiphene alone. This was a well-designed RCT with clinical fertility endpoints.
A 2018 Cochrane-style review by Thakker et al. analyzing multiple NAC trials in PCOS found consistent evidence for:
- Reduced fasting insulin and HOMA-IR
- Lower total testosterone and androstenedione
- Improved menstrual cycle regularity
- Improved ovulation rates (particularly as adjunct to clomiphene)
The limitations: many trials are from a single research group, sample sizes are moderate (50-180 women), and most trials are from Middle Eastern populations. Independent replication from Western research groups is limited. Still, the consistency across trials is notable.
Dosage used in trials and what to take
The dosage used in virtually all clinical PCOS trials is 1800mg/day, typically divided as 600mg three times per day with meals. This is also the dose most commonly used in NAC's other clinical applications (acetaminophen overdose treatment, cystic fibrosis, chronic bronchitis).
Some practitioners use lower doses—600mg once or twice daily (600-1200mg/day)—for general antioxidant support or mild insulin resistance, but the trial data supporting PCOS-specific outcomes used 1800mg/day consistently.
Practical dosing protocol:
- Start at 600mg once daily with a meal for week 1
- Increase to 600mg twice daily for week 2
- Increase to 600mg three times daily from week 3 onward
Starting at the full dose is generally tolerated (NAC has fewer GI issues than metformin or berberine) but stepping up is a reasonable precaution.
How long to take NAC for PCOS
The clinical trials showing hormonal effects ran for 12-24 weeks. Expecting meaningful androgen reduction or menstrual cycle changes in less than 3 months is unrealistic—the underlying mechanisms (glutathione replenishment, reduced ovarian oxidative stress, improved insulin sensitivity) take time to translate into hormonal changes.
Realistic timeline:
- Weeks 1-4: Antioxidant effects begin, some women notice reduced acne or improved energy
- Months 2-3: Insulin sensitivity markers improve, some androgen reduction begins
- Months 3-6: Most pronounced effects on cycle regularity, androgen levels, and (if applicable) ovulation
If you are using NAC for fertility specifically, most fertility-focused protocols run it for at least 3-6 months alongside any other fertility support. Continue during any monitored ovulation induction cycles.
Combining with inositol: a studied combination
Myo-inositol and NAC have complementary mechanisms that make their combination attractive and somewhat studied.
Inositol works on insulin signaling at the cellular level (second messenger for insulin receptor function). NAC works on oxidative stress upstream and downstream of insulin signaling. They address different aspects of PCOS physiology without significant overlap or negative interaction.
One studied combination: myo-inositol 4000mg + D-chiro-inositol 100mg (the 40:1 ratio) + NAC 600mg. Some Italian research groups have examined this combination in IVF and ovulation induction contexts with favorable outcomes, though this specific three-component combination is less extensively studied than inositol alone.
Alpha-lipoic acid (ALA) is another antioxidant that complements NAC by regenerating glutathione through a different pathway (via thioredoxin). Some practitioners use NAC 600mg + ALA 600mg as an antioxidant combination for PCOS, though head-to-head comparison with NAC alone is limited.
See myo-inositol for PCOS dosage and benefits for full detail on the inositol side of the combination.
What to expect: specific outcomes by PCOS profile
Not all PCOS presentations are the same, and NAC's benefits are most pronounced in specific profiles.
PCOS with insulin resistance (classic metabolic PCOS): Strongest evidence. NAC directly addresses the oxidative stress generated by hyperinsulinemia. Expect improvements in HOMA-IR, androgen levels, and menstrual regularity.
PCOS with elevated inflammatory markers: Strong rationale. NAC reduces NFkB-mediated inflammation and directly neutralizes ROS that drive inflammatory signaling.
Lean PCOS: Less studied specifically. Lean PCOS often has more dominant LH/FSH dysregulation rather than insulin resistance as the primary driver. NAC may still help through ovarian oxidative stress reduction, but the evidence is less robust than for insulin-resistant PCOS.
PCOS and fertility: Strong evidence for NAC as clomiphene adjunct. If you are pursuing ovulation induction, adding NAC to your protocol has meaningful RCT-level support.
Specific benefits to track
If you are using NAC for PCOS, these are the outcomes most likely to change and worth tracking:
Androgen markers: Total testosterone and free androgen index are the lab values most affected in trials. If you have baseline labwork, recheck at 3 and 6 months.
Cycle regularity: Track cycle length and frequency. Improved cycle regularity is one of the most consistently reported outcomes in NAC trials. Even going from cycles every 60-90 days to every 45-50 days is meaningful progress.
Insulin resistance markers: Fasting insulin and HOMA-IR improve in most trials. Fasting blood glucose alone is a poor indicator of insulin resistance improvement.
Acne and hair changes: These are androgen-mediated and often improve as testosterone decreases, but typically on a longer timeline (4-9 months).
Safety and who should not use NAC
NAC is considered safe for most healthy adults. Common mild side effects include nausea, vomiting, diarrhea, and occasionally headache—all more likely at higher doses and at the start of supplementation.
Pregnancy: NAC is actually considered relatively safe in pregnancy and is used clinically for acetaminophen overdose during pregnancy. Some fertility protocols continue NAC into early pregnancy. However, do not continue without discussing with your OB or fertility doctor.
Asthma: Inhaled NAC can trigger bronchospasm. Oral NAC at standard doses does not carry this risk, but note the contraindication for inhaled forms.
Blood thinners: NAC has mild antiplatelet and blood-thinning effects. Discuss with your prescriber if you are on warfarin, heparin, or antiplatelet medications.
Drug interactions: NAC can reduce the efficacy of nitroglycerin (used for chest pain) and theoretically interacts with immunosuppressants. Review your full medication list.
The bottom line
NAC has the most convincing clinical trial evidence of any supplement for PCOS after inositol. The head-to-head data against metformin is noteworthy—comparable insulin sensitizing effects with better tolerability. The dose is 1800mg/day (600mg three times daily with meals), and meaningful hormonal effects require 3-6 months of consistent use. NAC is most evidence-backed for insulin-resistant PCOS and as an adjunct to ovulation induction. Combining it with inositol provides complementary mechanisms without known negative interaction.
Track your supplement timing and results with Optimize. Start free.
Related Supplement Interactions
Learn how these supplements interact with each other
Omega-3 + Vitamin D3
Omega-3 fatty acids and Vitamin D3 are among the most commonly recommended supplements worldwide, an...
Berberine + Metformin
Berberine and Metformin are both powerful glucose-lowering agents that share remarkably similar mech...
St. John's Wort + SAMe
St. John's Wort and SAMe (S-Adenosyl-L-Methionine) should not be combined due to the risk of seroton...
5-HTP + SAMe
5-HTP and SAMe should not be taken together because both supplements increase serotonin levels throu...
Related Articles
More evidence-based reading
Akkermansia Muciniphila: The Gut Bacteria That Affects Metabolism and Weight
Akkermansia muciniphila is a keystone gut bacterium whose abundance strongly predicts metabolic health, gut barrier integrity, and response to weight loss interventions — and it can be deliberately cultivated.
8 min read →Resistant Starch for Gut Health: The Prebiotic That Changes Body Composition
Resistant starch is one of the few dietary compounds with simultaneous evidence for improving gut microbiome diversity, reducing postprandial glucose, and improving body composition — through mechanisms that are now well understood.
9 min read →Butyrate Supplements: What This Short-Chain Fatty Acid Does for Your Gut
Butyrate is the primary fuel source for colon cells and a critical regulator of gut barrier function, inflammation, and even gene expression — but supplementing it effectively is more complicated than it appears.
8 min read →